The Beauty Health Company's (SKIN) President and CEO to Depart
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
The Beauty Health Company (SKIN) plunges on Q3 miss as problems persist
November 14, 2023 9:09 AM ESTThe Beauty Health Company (NASDAQ: SKIN) shares plummeted more than 50% in premarket trading after the company missed consensus third-quarter estimates by a wide margin when it reported after the close on Monday.
The company reported a Q3 loss per share of $0.56, $0.63 worse than the analyst estimate of a profit of $0.07 per share. Meanwhile, revenue for the quarter came in at $97.4 million versus the consensus estimate of $116.23 million.
SKIN, home to flagship brand Hydrafacial, also revised its fiscal year 2023 net sales guidance to a range of $385 to $400 million, its fiscal year... More
